Showing results (2161-2170 of 5,041) with videos related to

Sort By:
Pageof 505
The British Journal of Dermatology|January 21, 2025
Melanoma: assessment and management summary of the 2022 update of the National Institute for Health and Care Excellence guidelinesMyles J Smith, Howard Peach, Steve Keohane, et al.
Journal of Hazardous Materials|December 6, 2024
Adsorption capacity and mechanism of modified coal fly ash (CFA) for per- and polyfluoroalkyl substances (PFAS) in landfill leachateHarsh V Patel, Myles Greer, Brian Brazil, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 16, 2024
Large Area Near-Field Thermophotovoltaics for Low Temperature ApplicationsJennifer Selvidge, Ryan M France, John Goldsmith, et al.
Advances in Health Information Science and Practice|September 22, 2025
The Accuracy of ChatGPT in Answering FAQs, Making Clinical Recommendations, and Categorizing Patient Symptoms: A Literature ReviewJohn Geracitano, Brittney Anderson, Melissa Coffel, et al.
Powder Technology|April 2, 2020
Atomic Force Microscopy to Identify Dehydration Temperatures for Small Volumes of Active Pharmaceutical IngredientsKatherine Atamanuk, Myles C Thomas, Robert C Wadams, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2020
Structure activity relationship exploration of 5-hydroxy-2-(3-phenylpropyl)chromones as a unique 5-HT2B receptor antagonist scaffoldMinsoo Kim, Myles Truss, Piyusha P Pagare, et al.
International Journal of Surgery (London, England)|June 21, 2017
Oral versus topical calcium channel blockers for chronic anal fissure-a systematic review and meta-analysis of randomized controlled trialsShaheel M Sahebally, Khalid Ahmed, Raminta Cerneveciute, et al.
Biology of Reproduction|June 23, 2017
Effect of simvastatin on baboon endometriosisHugh S Taylor, Myles Alderman Iii, Thomas M D'Hooghe, et al.
Organic Letters|November 20, 2023
Modular Total Synthesis of the 5/5-Spirocyclic SpiroindimicinsAnkush Banerjee, Tiffany A Brisco, Zhen Zhang, et al.
Dermatology (Basel, Switzerland)|August 14, 2023
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescents, and Adult Subjects (Ages 2 Years and Older) with Mild-to-Moderate Atopic DermatitisMichael E Jacobson, Ian A Myles, Amy S Paller, et al.
Pageof 505